KR101840079B1 - 폴리설페이트화된 폴리사카라이드에 의한 골수 부종(수종)의 치료 - Google Patents

폴리설페이트화된 폴리사카라이드에 의한 골수 부종(수종)의 치료 Download PDF

Info

Publication number
KR101840079B1
KR101840079B1 KR1020137022985A KR20137022985A KR101840079B1 KR 101840079 B1 KR101840079 B1 KR 101840079B1 KR 1020137022985 A KR1020137022985 A KR 1020137022985A KR 20137022985 A KR20137022985 A KR 20137022985A KR 101840079 B1 KR101840079 B1 KR 101840079B1
Authority
KR
South Korea
Prior art keywords
polysulfate
treatment
bone marrow
pps
bme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137022985A
Other languages
English (en)
Korean (ko)
Other versions
KR20140012655A (ko
Inventor
피터 고쉬
Original Assignee
패러다임 헬스 사이언시스 피티와이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011900325A external-priority patent/AU2011900325A0/en
Application filed by 패러다임 헬스 사이언시스 피티와이 리미티드 filed Critical 패러다임 헬스 사이언시스 피티와이 리미티드
Publication of KR20140012655A publication Critical patent/KR20140012655A/ko
Application granted granted Critical
Publication of KR101840079B1 publication Critical patent/KR101840079B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1020137022985A 2011-02-02 2012-02-02 폴리설페이트화된 폴리사카라이드에 의한 골수 부종(수종)의 치료 Active KR101840079B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2011900325 2011-02-02
AU2011900325A AU2011900325A0 (en) 2011-02-02 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides
PCT/AU2012/000091 WO2012103588A1 (en) 2011-02-02 2012-02-02 Treatment of bone marrow edema (oedema) with polysulfated polysaccharides

Publications (2)

Publication Number Publication Date
KR20140012655A KR20140012655A (ko) 2014-02-03
KR101840079B1 true KR101840079B1 (ko) 2018-03-19

Family

ID=46602012

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137022985A Active KR101840079B1 (ko) 2011-02-02 2012-02-02 폴리설페이트화된 폴리사카라이드에 의한 골수 부종(수종)의 치료

Country Status (15)

Country Link
US (6) US9101650B2 (https=)
EP (1) EP2670412B1 (https=)
JP (1) JP5883458B2 (https=)
KR (1) KR101840079B1 (https=)
CN (1) CN103415293B (https=)
AU (1) AU2012212398B2 (https=)
CA (1) CA2826166C (https=)
DK (1) DK2670412T3 (https=)
ES (1) ES2664611T3 (https=)
MY (1) MY164728A (https=)
NO (1) NO2670412T3 (https=)
PT (1) PT2670412T (https=)
SG (1) SG192238A1 (https=)
TW (1) TWI520740B (https=)
WO (1) WO2012103588A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2926888C (en) * 2013-10-22 2020-03-24 Cell Receptor Sa Modulation of the physical interaction between platelets and the cell surface effecting cell proliferation
WO2019023761A1 (en) * 2017-08-04 2019-02-07 Paradigm Biopharmaceuticals Ltd TREATMENT OF MEDICAL PATHOLOGIES WITH POLYSULFATED POLYSACCHARIDES
EP3813849A4 (en) 2018-02-16 2021-12-08 Proteobioactives Pty Limited METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN AND / OR INFLAMMATION
US11701382B2 (en) 2018-02-28 2023-07-18 Paradigm Biopharmaceuticals Ltd Treatment of post-operative joint pain with polysulfated polysaccharides
EP3863647B1 (en) * 2018-10-10 2024-02-14 Paradigm Biopharmaceuticals Limited Treatment of malignant bone pain with pentosan polysulfate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002041901A1 (en) 2000-11-21 2002-05-30 Arthropharm Pty Ltd Treatment of osteoporosis
WO2009070842A1 (en) 2007-12-04 2009-06-11 Proteobioactives Pty Ltd Protection of progenitor cells and regulation of their differentiation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668116A (en) 1987-03-19 1997-09-16 Anthropharm Pty. Limited Anti-inflammatory compounds and compositions
US6564083B2 (en) * 2000-12-18 2003-05-13 Hoffmann-La Roche Inc. Bone marrow edema as predictive of susceptibility to developing progressive osteoarthritis
DE10225551A1 (de) * 2002-06-06 2003-12-24 Schering Ag Verwendung von oral verfügbaren Prostacyclinderivaten für die Herstellung eines Arzneimittels zur Behandlung von Krankheiten, die mit Knochenmarködemen assoziiert sind

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002041901A1 (en) 2000-11-21 2002-05-30 Arthropharm Pty Ltd Treatment of osteoporosis
WO2009070842A1 (en) 2007-12-04 2009-06-11 Proteobioactives Pty Ltd Protection of progenitor cells and regulation of their differentiation

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Current Therapeutic Research. 2005. Vol.66, No.6, pp.552-571.

Also Published As

Publication number Publication date
EP2670412A4 (en) 2015-07-08
TWI520740B (zh) 2016-02-11
CA2826166A1 (en) 2012-08-09
MY164728A (en) 2018-01-30
DK2670412T3 (en) 2018-03-12
US20180021369A1 (en) 2018-01-25
US20220362284A1 (en) 2022-11-17
JP5883458B2 (ja) 2016-03-15
AU2012212398A1 (en) 2013-09-19
SG192238A1 (en) 2013-09-30
JP2014504613A (ja) 2014-02-24
EP2670412B1 (en) 2018-01-03
ES2664611T3 (es) 2018-04-20
CA2826166C (en) 2017-05-09
CN103415293B (zh) 2016-08-10
US10610542B2 (en) 2020-04-07
US20140024614A1 (en) 2014-01-23
TW201309307A (zh) 2013-03-01
NO2670412T3 (https=) 2018-06-02
US9861657B2 (en) 2018-01-09
US20210015849A1 (en) 2021-01-21
WO2012103588A1 (en) 2012-08-09
US9101650B2 (en) 2015-08-11
EP2670412A1 (en) 2013-12-11
US20150297633A1 (en) 2015-10-22
US20240156858A1 (en) 2024-05-16
US11406660B2 (en) 2022-08-09
AU2012212398B2 (en) 2014-06-05
CN103415293A (zh) 2013-11-27
KR20140012655A (ko) 2014-02-03
PT2670412T (pt) 2018-03-20

Similar Documents

Publication Publication Date Title
Edelson et al. Short-Term Effects of Knee Washout for Osteoarth ritis
US20240156858A1 (en) Treatment of Bone Marrow Edema (Oedema) With Polysulfated Polysaccharides
Santos et al. Cartilage lesions and ankle osteoarthrosis: review of the literature and treatment algorithm
Herman et al. 41 Complications of tibial eminence and diaphyseal fractures in children: prevention and treatment
van Roermund et al. Joint distraction in the treatment of ankle osteoarthritis
Barakat et al. Prevention of post-traumatic osteoarthritis after intra-articular knee fractures using hyaluronic acid: a randomized prospective pilot study
Afzal et al. Study to determine the efficacy of illizarov fixator for the treatment of complex tibial plateau fractures
Manjunath et al. A prospective study of surgical management of bicondylar schatzker type V & VI tibial plateau fracture by dual plating and dual incision
Specchiulli et al. Peritalar dislocations
Barner et al. Simultaneous bilateral rupture of patellar tendons in a young man without predisposing factors or systemic disease
Saluta et al. Managing foot and ankle injuries in athletes
Gu et al. Effect of internal fixation of tibial fracture with suprapatellar approach and subpatellar approach on fracture union and knee function recovery
Street et al. Atraumatic medullary osteonecrosis of the tibia and femur treated with intraosseous orthobiologics
Zhang et al. Single-incision Non-weight-bearing Area Autologous Osteochondral Transplantation for the Treatment of Osteochondral Lesions of the Talus
Soni Functional Outcome in Management of Open Tibial Diaphyseal Fractures by Limb Reconstruction System as Primary and Definitive Tool-A Prospective Study
Adukia et al. Journal of Arthroscopy and Joint Surgery
Sheeraz Prevention and Postoperative Care
陳柏旭 et al. The improvement of pain symptoms and activities of daily living in people with knee osteoarthritis after intra-articular hyaluronic acid injection
Murrell WD Murrell
Puri Clinical study on the management of complex metaphyseal fractures of the tibia (proximal and distal) with hybrid external fixation
Montaser Arthroscopic treatment of traumatic anterior bony ankle impingement
Stapp Joel V. Ferreira, Vinayak M. Sathe, Michael Aronow, and
Rosario Saccomanno et al. Monthly Archives: December 2020
Shamsi et al. Yearly Archives: 2012

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 8